» Articles » PMID: 35098445

Relationship Between Serum Levels of Arsenic, Cadmium, and Mercury and Body Mass Index and Fasting Plasma Glucose in a Mexican Adult Population

Abstract

In Mexico, few studies have analyzed the associations between toxic elements and metabolic diseases. In the present study, we analyzed the associations between serum arsenic (As), cadmium (Cd), and mercury (Hg) levels and body mass index (BMI) and fasting plasma glucose (FPG) in a Mexican adult population. Anthropometric data corresponding to 86 Mexican healthy adults (59 females and 27 men) were analyzed. FPG was analyzed by an enzymatic colorimetric method, and serum As, Cd, and Hg levels were analyzed by inductively coupled plasma-mass spectrometry (ICP-MS). The data show that the median serum As, Cd, and Hg levels were relatively higher in females (As = 1.78 ng mL, Cd = 1.00 ng mL, Hg = 0.96 ng mL) than those in males (As = 1.22 ng mL, Cd = 0.91 ng mL, Hg = 0.95 ng mL). However, these differences were not statistically significant (p ≥ 0.097). We also found that the median level of As significantly increased with an increase in the body weight categories (normal weight = 1.08; overweight = 1.50; obesity = 2.75; p < 0.001). In addition, a positive association between serum As levels and FPG before and after adjustment for BMI was demonstrated (Rho = 0.012; (RhoA = 0.243, p = 0.032). Serum As levels are positively associated with BMI and FPG in the adult population of Mexico. Nevertheless, these results need to be replicated and confirmed with a larger sample size.

Citing Articles

Metal mixtures and adiposity indicators in women from Northern Mexico.

Flores-Collado G, Merida-Ortega A, Lopez-Carrillo L Biometals. 2025; .

PMID: 39833489 DOI: 10.1007/s10534-024-00661-7.


Recent advances in the application of ionomics in metabolic diseases.

Zhang Y, Huang B, Jin J, Xiao Y, Ying H Front Nutr. 2023; 9:1111933.

PMID: 36726817 PMC: 9884710. DOI: 10.3389/fnut.2022.1111933.


Mercury Exposure and Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Ghorbani Nejad B, Raeisi T, Janmohammadi P, Mehravar F, Zarei M, Dehghani A Int J Clin Pract. 2022; 2022:7640227.

PMID: 36101810 PMC: 9463027. DOI: 10.1155/2022/7640227.


Exploring the Effects of Energy Constraints on Performance, Body Composition, Endocrinological/Hematological Biomarkers, and Immune System among Athletes: An Overview of the Fasting State.

Nobari H, Saedmocheshi S, Murawska-Cialowicz E, Clemente F, Suzuki K, Silva A Nutrients. 2022; 14(15).

PMID: 35956373 PMC: 9370338. DOI: 10.3390/nu14153197.

References
1.
Su C, Lin H, Choy C, Huang Y, Huang S, Hsueh Y . The relationship between obesity, insulin and arsenic methylation capability in Taiwan adolescents. Sci Total Environ. 2011; 414:152-8. DOI: 10.1016/j.scitotenv.2011.10.023. View

2.
Tinkov A, Filippini T, Ajsuvakova O, Aaseth J, Gluhcheva Y, Ivanova J . The role of cadmium in obesity and diabetes. Sci Total Environ. 2017; 601-602:741-755. DOI: 10.1016/j.scitotenv.2017.05.224. View

3.
Ceja-Galicia Z, Daniel A, Salazar A, Panico P, Ostrosky-Wegman P, Diaz-Villasenor A . Effects of arsenic on adipocyte metabolism: Is arsenic an obesogen?. Mol Cell Endocrinol. 2017; 452:25-32. DOI: 10.1016/j.mce.2017.05.008. View

4.
Castriota F, Acevedo J, Ferreccio C, Smith A, Liaw J, Smith M . Obesity and increased susceptibility to arsenic-related type 2 diabetes in Northern Chile. Environ Res. 2018; 167:248-254. PMC: 6277209. DOI: 10.1016/j.envres.2018.07.022. View

5.
Filippini T, Wise L, Vinceti M . Cadmium exposure and risk of diabetes and prediabetes: A systematic review and dose-response meta-analysis. Environ Int. 2021; 158:106920. DOI: 10.1016/j.envint.2021.106920. View